Auriga initiates coverage on MedAssets (Nasdaq: MDAS) with a Buy. Price target $20.

Auriga analyst says, "MDAS’ solutions tackle two ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE